MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
8.49
+0.63
+8.02%
After Hours: 8.49 0 0.00% 16:10 02/06 EST
OPEN
7.86
PREV CLOSE
7.86
HIGH
8.67
LOW
7.82
VOLUME
62.39K
TURNOVER
--
52 WEEK HIGH
34.27
52 WEEK LOW
3.600
MARKET CAP
72.09M
P/E (TTM)
-0.2558
1D
5D
1M
3M
1Y
5Y
1D
Scilex Holding Files Procedural Update on Security Holder Rights
TipRanks · 4d ago
Scilex Expands Strategic Equity Stake in Quantum Scan
TipRanks · 5d ago
Weekly Report: what happened at SCLX last week (0126-0130)?
Weekly Report · 5d ago
Scilex announces $20M strategic investment in Quantum Scan
TipRanks · 01/30 14:11
Scilex Holding Makes $20M Strategic Investment In Quantum Scan Holdings To Identify, Develop, And Deploy Innovative Medical Technologies
Benzinga · 01/30 14:07
Scilex Holding Company Invests $20 Million in Quantum Scan Holdings
Reuters · 01/30 14:00
SCILEX HOLDING COMPANY ANNOUNCES $20 MILLION STRATEGIC INVESTMENT IN QUANTUM SCAN HOLDINGS, INC., TARGETING TRILLION-DOLLAR PREVENTIVE DIAGNOSIS AND PROGNOSIS MARKETS
Reuters · 01/30 14:00
Weekly Report: what happened at SCLX last week (0119-0123)?
Weekly Report · 01/26 09:47
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.